{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:20:10Z","timestamp":1777299610873,"version":"3.51.4"},"reference-count":33,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T00:00:00Z","timestamp":1304553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Dermatology"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ciclosporin is an immunosuppressive drug that has been used to treat allergies and other immune\u2010mediated diseases in cats, dogs and humans. Information about the adverse effects of ciclosporin in cats has been limited to smaller studies and case reports. Adverse effects in dogs are mainly gastrointestinal in nature, but humans can also experience hypertension and altered renal function. The aim of this retrospective case series study was to document the occurrence and clinical appearance of adverse events in cats receiving ciclosporin to treat allergic skin disease. The medical records of 50 cats with allergic dermatitis treated with oral ciclosporin (1.9\u20137.3\u2003mg\/kg\/day) were reviewed. Adverse events occurred in 66% (33 cats). Adverse events likely to be associated with ciclosporin included the following: vomiting or diarrhoea within 1\u20138\u2003weeks of receiving ciclosporin (24%), weight loss (16%), anorexia and subsequent hepatic lipidosis (2%) and gingival hyperplasia (2%). Other adverse events less likely to be associated with ciclosporin therapy included the following: weight gain (14%), dental tartar and gingivitis (10%), otitis (4%), chronic diarrhoea (4%), inflammatory bowel disease with indolent gastrointestinal lymphoma (2%), urinary tract infection (2%), cataract (2%), elevated liver enzymes (2%), hyperthyroidism and renal failure (2%) and transient inappropriate urination (2%). Some cats experienced multiple adverse events. Case\u2013control studies are needed to prove cause and effect of ciclosporin with regard to these adverse events.<\/jats:p>","DOI":"10.1111\/j.1365-3164.2011.00983.x","type":"journal-article","created":{"date-parts":[[2011,5,5]],"date-time":"2011-05-05T12:27:28Z","timestamp":1304598448000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Adverse events in 50 cats with allergic dermatitis receiving ciclosporin"],"prefix":"10.1111","volume":"22","author":[{"given":"Nicole A.","family":"Heinrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa C.","family":"Eisenschenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,5]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"534","volume-title":"Muller and Kirk\u2019s Small Animal Dermatology","author":"Scott DW","year":"2001"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.5326\/0450215"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2006.00110.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2007.11.018"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/vr.152.24.739"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.2006.tb13119.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2004.00371.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1053\/jvet.2002.30540"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5829.2008.00172.x"},{"key":"e_1_2_6_11_2","first-page":"377","article-title":"Clinical evaluation of cyclosporine in animal models with cutaneous immune\u2010mediated disease and epitheliotropic lymphoma","volume":"25","author":"Rosenkrantz WS","year":"1989","journal-title":"Journal of the American Animal Hospital Association"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(86)90095-4"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-950X.2008.00373.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2005.00491.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.02.062"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jbchem.a003063"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2005.03.012"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.70.1011"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.11.055"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.01709.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/030098589803500405"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1354\/vp.39-2-228"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5571"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_6_25_2","volume-title":"R: A language and environment for statistical computing","year":"2011"},{"key":"e_1_2_6_26_2","first-page":"1","article-title":"Study designs in paediatric pharmacoepidemiology","author":"Verhamme K","journal-title":"European Journal of Clinical Pharmacology"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831010-00003"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1990.tb02882.x"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.2006.tb02852.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21475"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.5507\/bp.2009.043"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/jsre.2001.6233"},{"key":"e_1_2_6_33_2","first-page":"754","volume-title":"Infectious Diseases of the Dog and Cat","author":"Dubey JP","year":"2006"},{"key":"e_1_2_6_34_2","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]","author":"Higgin JPT","year":"2009"}],"container-title":["Veterinary Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-3164.2011.00983.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-3164.2011.00983.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T01:18:21Z","timestamp":1697246301000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-3164.2011.00983.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,5]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["10.1111\/j.1365-3164.2011.00983.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-3164.2011.00983.x","archive":["Portico"],"relation":{},"ISSN":["0959-4493","1365-3164"],"issn-type":[{"value":"0959-4493","type":"print"},{"value":"1365-3164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,5]]},"assertion":[{"value":"2011-05-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}